Day One Biopharmaceuticals, Inc. entered into an underwriting agreement to issue and sell 11,538,462 shares of its common stock at a public offering price of $13.00 per share, with an option for the underwriters to purchase additional shares. The gross proceeds from the offering are estimated to be approximately $150.0 million.